At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of the Supplementation With a Symbiotic, a Prebiotic and a Probiotic to Produce a Beneficial Effect on the Intestinal Microbiota and on the Characteristics of Feces in Children With Cerebral Palsy (CP) and Chronic Constipation
In Brief
A Phase 4 clinical trial evaluating agave inulin, Lactobacillus reuteri DSM 17938, and 2 other interventions for Cerebral Palsy and Chronic Constipation. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Randomized double blind controlled clinical trial. Participants will be enrolled at the New Civil Hospital of Guadalajara "Dr. Juan I. Menchaca" during the period from May 2017 to July 2018, from six to 59 months of either sex. The duration of each participant in the study will be of four weeks. Each participant will be randomized assigned to any of the different study groups: synbiotic, prebiotic, probiotic or placebo. Hypothesis: The efficacy of supplementation with a symbiotic, a prebiotic and a probiotic differs in its beneficial effect on the intestinal microbiota and the characteristics of feces in children with CP and chronic constipation.
Study Details
Timeline
Interventions
Duration: four weeks Dosage: powder 4 g/d
Duration: four weeks Dosage: 5 drops/d
Duration: four weeks Dosage: powder 4 g/d
Duration: four weeks Dosage: 5 drops/d